The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.

The scope includes: Behavioural pharmacology, Neuropharmacology and psychopharmacology, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, Molecular and cellular pharmacology, Regenerative pharmacology, Biologicals and biotherapeutics, Translational pharmacology and Nutriceutical pharmacology.

The journal publishes full-length papers and reviews. Ethnopharmacological studies with plant extracts or mixtures are not in scope of this journal.


The table of contents for this journal is now available pre-publication, via e-mail, as part of the free ContentsDirect service from Elsevier. Please send an e-mail message to cdhelp@elsevier.co.uk for further information about this service.


Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

ScienceDirect Backfiles

Research Paper
Review Article

Editor in Chief
Frank A. Redegeld
Utrecht University Department of Pharmaceutical Sciences, Utrecht, Netherlands
Editors
Gert Folkerts
Utrecht University, Utrecht, Netherlands
Marek Los
LinkoCare Life Sciences AB, Linköping, Sweden
Lucianne Groenink
Utrecht University, Utrecht, Netherlands
Ferdi Engels
Utrecht University, Utrecht, Netherlands
Paul A. J. Henricks
Utrecht University, Utrecht, Netherlands
Aleksandar Jovanović
University of Nicosia Medical School, Lefkosia, Cyprus
Zhonghong Gao, PhD
Huazhong University of Science and Technology, Wuhan, China
Review Editor
George Booz
University of Mississippi Department of Biomolecular Sciences Division of Pharmacology, Jackson, Mississippi, United States
Editorial Board
I.M. Adcock
Imperial College London, London, United Kingdom
P. Alberts
O.A. Andreassen
University of Oslo, Oslo, Norway
L.J. Barthó
University of Pecs, Pecs, Hungary
M.H. Baumann
National Institutes of Health, Bethesda, Maryland, United States
E. Beubler
University of Graz, Graz, Austria
G. Biggio
University of Cagliari School of Biology and Pharmacy, Monserrato, Italy
A. Brack
University Hospital Wurzburg, Wurzburg, Germany
J. Burk
William & Mary, Williamsburg, Virginia, United States
Y. Cao
Scripps Research Institute Department of Neuroscience, Jupiter, Florida, United States
C.H. Cho
Chinese University of Hong Kong Faculty of Medicine, Shatin, Hong Kong
K.F. Chung, MD, DSc, FRCP
National Heart and Lung Institute, London, England, United Kingdom
A. Colquhoun
University of Sao Paulo, São Paulo, Brazil
A.H.J. Danser
Erasmus University Rotterdam, Rotterdam, Netherlands
N.A. Darmani
Western University of Health Sciences, Pomona, California, United States
C. Davidson
University of Central Lancashire School of Pharmacy and Biomedical Sciences, Preston, United Kingdom
G. Di Chiara
University of Cagliari, Cagliari, Italy
M. DiLuca
University of Milan, Milano, Italy
M. Diener
University of Giessen, Gießen, Germany
J. Ding
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, China
F. Drago
University of Catania, Catania, Italy
M.S. Elisaf
University of Ioannina Faculty of Medicine, Ioannina, Greece
M. Endoh
Yamagata University, Yamagata, Japan
W. Faour
Lebanese American University Byblos Campus, Byblos, Lebanon
J.G. Filep
University of Montreal, Montreal, Quebec, Canada
H.-J. Freisleben
J.A. García-Sáinz
National Autonomous University of Mexico, Mexico City, Mexico
K.B. Glaser
AbbVie Inc, North Chicago, Illinois, United States
R. Gosens
University of Groningen, Groningen, Netherlands
R. Gozzelino
New University of Lisbon, Lisboa, Portugal
A.R. Green
AstraZeneca PLC, Cambridge, United Kingdom
J. Haller
Hungarian Academy of Sciences Department of Behavioral Neurobiology, Budapest, Hungary
M.D. Hamon
National Institute of Health and Medical Research, Paris, France
Y. Hattori
University of Toyama Department of Molecular and Medical Pharmacy, Toyama, Japan
D. Heymann, PhD
Institute of Cancer Research Western France, Saint-Herblain, France
M. Hiramatsu
Meijo University, Nagoya, Japan
U. Holzer-Petsche
Medical University of Graz, Graz, Austria
S.T. Hou
NRC Institute for Biological Sciences, Ottawa, Ontario, Canada
J. Kamei
Hoshi University Graduate School of Pharmaceutical Sciences, Shinagawa-Ku, Japan
G. Kolios
Democritus University of Thrace Department of Medicine, Alexandroupolis, Greece
J. Kotlinska
Medical University of Lublin, Lublin, Poland
T.F. Krzemiński
Medical University of Silesia School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Zabrze, Poland
X.J. Li
Peking University, Beijing, China
Y. Li
UNIVERSITY OF NEBRASKA MEDICAL CENTER, Omaha, Nebraska, United States
R. Loewe
Medical University of Vienna, Wien, Austria
W. Löscher
University of Veterinary Medicine Hannover, Hannover, Germany
M. Maczewski
Medical Centrum for Postgraduate Studies, Warszawa, Poland
J.G. de Man
University of Antwerp, Antwerpen, Belgium
J.J. Moreno
University of Barcelona, Barcelona, Spain
G. Müller
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
F. Nicoletti, Ph.D.
University of Catania Department of Biomedical and Biotechnological Sciences, Catania, Italy
J.N. Pennefather
Monash University Faculty of Pharmacy and Pharmaceutical Sciences, Parkville, Australia
C. Peralta
August Pi i Sunyer Institute of Biomedical Research, Barcelona, Spain
A. Pertovaara
University of Helsinki, Helsinki, Finland
J.M. Pfeilschifter
Hospital of the Goethe University Frankfurt Pharmacology Centre, Frankfurt am Main, Germany
R.C. Pierce
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
J.P.R. Pin
Institute of Functional Genomics, Montpellier, France
D. Platt
New England Primate Research Center, Southborough, Massachusetts, United States
M. Pouliot
Laval University, Quebec, Canada
R. Przewlocki
Institute of Pharmacology of the Polish Academy of Sciences Department of Molecular Neuropharmacology, Krakow, Poland
M.E.A. Reith
NEW YORK UNIVERSITY SCHOOL OF MEDICINE, New York, New York, United States
F.L.M. Ricciardolo
University of Turin, Torino, Italy
M. Rodriguez-Arias
University of Valencia, Valencia, Spain
F.G.M. Russel
Radboudumc Department of Pharmacology and Toxicology, Nijmegen, Netherlands
A. Sebastião
University of Lisbon, Lisboa, Portugal
N. Sharif
Alcon Laboratories Inc, Fort Worth, Texas, United States
T. Simeone
Creighton University, Omaha, Nebraska, United States
P. Skolnick
Opiant Pharmaceuticals, Santa Monica, California, United States
B. Stieger
University of Zurich, Zürich, Switzerland
K. Tanonaka
Tokyo University of Pharmacy and Life Science School of Pharmacy Department of Molecular and Cellular Pharmacology, Tokyo, Japan
H. Tsuchiya
Tottori University, Tottori, Japan
M. Tuncer
Hacettepe University, Ankara, Turkey
L. Ver Donck, PhD
Janssen Research and Development Beerse, Beerse, Belgium
B.J.R. Whittle
Saint Bartholomew's Hospital, London, United Kingdom
Founded in 1967
Founding Editors
David De Wied
Jacques van Rossum